Causal Associations Between Modifiable Risk Factors and the Alzheimer's Phenome
- PMID: 32996171
- PMCID: PMC8088901
- DOI: 10.1002/ana.25918
Causal Associations Between Modifiable Risk Factors and the Alzheimer's Phenome
Abstract
Objective: The purpose of this study was to infer causal relationships between 22 previously reported risk factors for Alzheimer's disease (AD) and the "AD phenome": AD, AD age of onset (AAOS), hippocampal volume, cortical surface area and thickness, cerebrospinal fluid (CSF) levels of amyloid-β (Aβ42 ), tau, and ptau181 , and the neuropathological burden of neuritic plaques, neurofibrillary tangles (NFTs), and vascular brain injury (VBI).
Methods: Polygenic risk scores (PRS) for the 22 risk factors were computed in 26,431 AD cases/controls and the association with AD was evaluated using logistic regression. Two-sample Mendelian randomization (MR) was used to infer the causal effect of risk factors on the AD phenome.
Results: PRS for increased education and diastolic blood pressure were associated with reduced risk for AD. MR indicated that only education was causally associated with reduced risk of AD, delayed AAOS, and increased cortical surface area and thickness. Total- and LDL-cholesterol levels were causally associated with increased neuritic plaque burden, although the effects were driven by single nucleotide polymorphisms (SNPs) within the APOE locus. Diastolic blood pressure and pulse pressure are causally associated with increased risk of VBI. Furthermore, total cholesterol was associated with decreased hippocampal volume; smoking initiation with decreased cortical thickness; type 2 diabetes with an earlier AAOS; and sleep duration with increased cortical thickness.
Interpretation: Our comprehensive examination of the genetic evidence for the causal relationships between previously reported risk factors in AD using PRS and MR supports a causal role for education, blood pressure, cholesterol levels, smoking, and diabetes with the AD phenome. ANN NEUROL 2021;89:54-65.
© 2020 American Neurological Association.
Conflict of interest statement
Potential Conflicts of Interest
S.J.A., B.F.H., E.M., P.F.O., and A.M.G. have no conflicts of interest to declare.
Figures
References
-
- Alzheimer’s Association. 2020 Alzheimer’s disease facts and figures. Alzheimer’s Dement 2020;16:391–460.
-
- Livingston G, Sommerlad A, Orgeta V, et al. Dementia prevention, intervention, and care. Lancet 2017;390:2673–2734. - PubMed
-
- World Health Organization, Risk Reduction of Cognitive Decline and Dementia: WHO Guidelines 2019. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- RC2 AG036528/AG/NIA NIH HHS/United States
- U24 AG021886/AG/NIA NIH HHS/United States
- U24 AG072122/AG/NIA NIH HHS/United States
- P50 AG008702/AG/NIA NIH HHS/United States
- U01 AG016976/AG/NIA NIH HHS/United States
- U24 AG056270/AG/NIA NIH HHS/United States
- S10 OD026880/OD/NIH HHS/United States
- K99 AG070109/AG/NIA NIH HHS/United States
- R01 MH122866/MH/NIMH NIH HHS/United States
- MR/N015746/1/MRC_/Medical Research Council/United Kingdom
- RF1 AG044546/AG/NIA NIH HHS/United States
- U01 AG058635/AG/NIA NIH HHS/United States
- U01 AG052411/AG/NIA NIH HHS/United States
- U01 AG032984/AG/NIA NIH HHS/United States
- U24 AG041689/AG/NIA NIH HHS/United States
- K23 AG000946/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
